Home

Fueling health policy solutions through scholarship and science.

  • Issue Brief • 03/12/24

    Considerations for FDA’s New Advanced Pharmaceutical Manufacturing Programs

    Learn More Here
  • Event • 03/12/24

    Fostering Collaboration to Advance Representative Enrollment in Clinical Trials

    Learn More Here
  • White Paper • 03/12/24

    Modernizing Medicare Risk Adjustment and Performance Measurement

    Read More
  • Event • 03/12/24

    Duke-Margolis 2024 Annual Health Policy Conference

    Register Today
  • Topic • 03/12/24

    Join Us in Our Emerging Initiatives

    Learn More

Focus Area

Cross-Cutting Themes

Newsletter

Stay current on the latest from Duke-Margolis Institute by subscribing to our newsletters.

Duke-Margolis Spotlight

On December 5, 2023, Duke-Margolis hosted a public meeting to introduce a strategic framework outlining core areas for improvement across the hepatitis C care cascade, the implementation pathway for reaching each of the key populations, and supportive evidence and lessons learned from past and ongoing public health and healthcare delivery transformation programs. Senator Chris Van Hollen (MD) spoke with Dr. McClellan about the bipartisan legislative efforts which aim to reduce death and disease, improve detection and response, while also providing a cost savings almost $8 billion savings over the next 10 years.

Giving

Thank you for your interest in making a gift to the Duke-Margolis Institute for Health Policy.